Id |
Subject |
Object |
Predicate |
Lexical cue |
T194 |
7-12 |
NN |
denotes |
death |
T195 |
14-18 |
RB |
denotes |
Also |
T196 |
18-19 |
-COMMA- |
denotes |
, |
T197 |
20-23 |
DT |
denotes |
the |
T198 |
24-40 |
JJ |
denotes |
pro-inflammatory |
T199 |
41-49 |
NN |
denotes |
cytokine |
T200 |
50-53 |
NN |
denotes |
IL6 |
T201 |
54-56 |
VBZ |
denotes |
is |
T202 |
57-60 |
DT |
denotes |
the |
T203 |
61-76 |
JJ |
denotes |
best-documented |
T204 |
77-85 |
NN |
denotes |
cytokine |
T205 |
86-88 |
IN |
denotes |
in |
T206 |
89-97 |
NN |
denotes |
COVID-19 |
T207 |
98-108 |
VBD |
denotes |
correlated |
T208 |
109-113 |
IN |
denotes |
with |
T209 |
114-122 |
NN |
denotes |
severity |
T210 |
122-123 |
-COMMA- |
denotes |
, |
T211 |
124-135 |
NN |
denotes |
criticality |
T212 |
135-136 |
-COMMA- |
denotes |
, |
T213 |
137-142 |
JJ |
denotes |
viral |
T214 |
143-147 |
NN |
denotes |
load |
T215 |
147-148 |
-COMMA- |
denotes |
, |
T216 |
149-152 |
CC |
denotes |
and |
T217 |
153-162 |
NN |
denotes |
prognosis |
T218 |
163-165 |
IN |
denotes |
of |
T219 |
166-174 |
NNS |
denotes |
patients |
T220 |
175-179 |
IN |
denotes |
with |
T221 |
180-188 |
NN |
denotes |
COVID-19 |
T222 |
190-201 |
NNP |
denotes |
Tocilizumab |
T223 |
201-202 |
-COMMA- |
denotes |
, |
T224 |
203-204 |
DT |
denotes |
a |
T225 |
205-215 |
JJ |
denotes |
monoclonal |
T226 |
216-224 |
NN |
denotes |
antibody |
R187 |
T201 |
T195 |
arg1Of |
is,Also |
R188 |
T201 |
T196 |
arg1Of |
is,"," |
R189 |
T200 |
T197 |
arg1Of |
IL6,the |
R190 |
T200 |
T198 |
arg1Of |
IL6,pro-inflammatory |
R191 |
T200 |
T199 |
arg1Of |
IL6,cytokine |
R192 |
T200 |
T201 |
arg1Of |
IL6,is |
R193 |
T204 |
T201 |
arg2Of |
cytokine,is |
R194 |
T204 |
T202 |
arg1Of |
cytokine,the |
R195 |
T204 |
T203 |
arg1Of |
cytokine,best-documented |
R196 |
T204 |
T205 |
arg1Of |
cytokine,in |
R197 |
T216 |
T205 |
arg2Of |
and,in |
R198 |
T206 |
T207 |
arg2Of |
COVID-19,correlated |
R199 |
T207 |
T208 |
arg1Of |
correlated,with |
R200 |
T209 |
T208 |
arg2Of |
severity,with |
R201 |
T209 |
T210 |
arg1Of |
severity,"," |
R202 |
T211 |
T210 |
arg2Of |
criticality,"," |
R203 |
T206 |
T212 |
arg1Of |
COVID-19,"," |
R204 |
T214 |
T212 |
arg2Of |
load,"," |
R205 |
T214 |
T213 |
arg1Of |
load,viral |
R206 |
T216 |
T215 |
arg1Of |
and,"," |
R207 |
T212 |
T216 |
arg1Of |
",",and |
R208 |
T217 |
T216 |
arg2Of |
prognosis,and |
R209 |
T217 |
T218 |
arg1Of |
prognosis,of |
R210 |
T219 |
T218 |
arg2Of |
patients,of |
R211 |
T219 |
T220 |
arg1Of |
patients,with |
R212 |
T221 |
T220 |
arg2Of |
COVID-19,with |
R213 |
T222 |
T223 |
arg1Of |
Tocilizumab,"," |
R214 |
T226 |
T223 |
arg2Of |
antibody,"," |
R215 |
T226 |
T224 |
arg1Of |
antibody,a |
R216 |
T226 |
T225 |
arg1Of |
antibody,monoclonal |